Although these drugs are effective, the use of anti-VEGF drugs has several disadvantages, such as transient effects and the need for repeated injections resulting in retinal detachment (in some cases) or endophthalmitis (in rare cases) [149]. This evidence concerns the gene VEGFA and endophthalmitis.